A Sterling, CDMO leader

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Cook, CEO at Sterling Pharma Solutions.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering:

• Decades of mixed ownership and conflicting business models led to lots of character-building learnings... and the rebirth of Sterling
• The power of a rebrand and sense of togetherness to gain commercial traction
• Kevin’s five-point M&A playbook that’s helped drive exponential, transatlantic growth
• Why culture and people are the hardest things when scaling from 180 colleagues on one site to a 1300+ strong team across six sites
• The robustness of small molecules, on-shoring back to the West and reasons to be optimistic for the future

Kevin has over 30 years of experience in the pharmaceutical industry. He started working with Robinson Brothers as an Assistant Plant Manager before progressing to Senior Plant Manager. Kevin then joined Boots Pharmaceuticals with responsibility for commissioning activities on a new pharmaceutical plant.

In 1993 Kevin joined Sterling Organics and has supported the site through several mergers and acquisitions over 18 years. At that time, he was Operations Director for Chirex, Industrial Director for Rhodia Pharma Solutions, and President of Shasun Pharma Solutions.

In 2010, Kevin joined Aesica Pharmaceuticals as the Managing Director for the API business unit with a clear focus on growth through increasing the customer and product portfolio. Kevin returned to Shasun Pharma Solutions in 2013 to take responsibility for all commercial activities relating to the pharmaceutical service business. Having overseen the launch of Sterling Pharma Solutions as an independent CDMO, he was appointed CEO, President, and Board Member.

 

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.